Drug-induced stress signaling as measured by pan JNK activation has been shown to induce TNC and osteopontin (OPN), counteracting its potential as anti-cancer treatment, but inhibition of JNK (thus downregulating TNC and OPN) could sensitize breast cancer patients to chemotherapy (Insua-Rodriguez et al., 2018). Here, MAPK8 is linked to breast carcinoma.